deltatrials

University of Washington Clinical Trials

Sponsors / University of Washington

University of Washington appears as lead sponsor on 318 trial records in ClinicalTrials.gov. Of these, 41 are recruiting, 11 are active without new recruitment, and 197 have completed. The registry records 20 terminated or withdrawn trials for University of Washington. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Planned participant enrollment across these trials sums to 109,018. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.

318
Total Trials
41
Recruiting
11
Other Active
197
Completed
20
Terminated / Withdrawn
109,018
Total Enrollment

Termination reasons: Recruitment55% · Other20% · Funding20% · Efficacy5%

Recent Terminations

  • NCT03442556 Phase PHASE2 Stopped Jun 2025
    ATM Gene Mutation
    "Terminated due to insufficient funding"
  • NCT06577571 Phase NA Stopped Dec 2024
    Kidney Disease, Chronic
    "Low recruitment, insufficient funds"
  • NCT03486197 Phase PHASE2 Stopped May 2024
    Urothelial Carcinoma
    "Closed per SRC Low Accrual Policy"
  • NCT04196010 Phase PHASE1 Stopped Oct 2021
    Myeloid Neoplasm
    "Terminated due to unfavorable risk-benefit ratio of investigational regimen."
  • NCT03806192 Phase NA Stopped Nov 2020
    Acute Myeloid Leukemia
    "Terminated due to insufficient funding"
  • NCT03924622 Phase NA Stopped Sep 2020
    Military Activity
    "Unable to continue to conduct study procedures due to pandemic"
  • NCT03723863 Phase NA Stopped Sep 2020
    Breast Cancer
    "Study team determined that data collected was appropriate for study outcome goals."
  • NCT04216173 Phase NA Stopped Mar 2020
    Post-Traumatic Headache
    "Permanent suspension of all study activities due to COVID-19 and subsequent loss of funding."
  • NCT03064009 Stopped May 2018
    Infection
    "Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. Low enrollment and PI leaving institution"
  • NCT03042546 Phase PHASE4 Stopped May 2018
    Open tíbia Fracture With Sub-segmental Bone Loss
    "Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. Low enrollment and PI leaving institution"

Active Trials (11 total)

Top Conditions

Multiple sclerosis (6) Anxiety (5) Spinal cord injuries (5) Amputation (4) Breast cancer (4) Pain (4) Acute myeloid leukemia (3) Anatomic stage iv breast cancer ajcc v8 (3) Bipolar disorder (3) Depression (3)

Top Locations

Seattle, United States (270) Portland, United States (4) Renton, United States (4) Boston, United States (3) Spokane, United States (3) Tacoma, United States (3) São Paulo, Brazil (2) Nairobi, Kenya (2) Hillbrow, South Africa (2) Atlanta, United States (2)